U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H7O.Na
Molecular Weight 130.1196
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SODIUM P-CRESOLATE

SMILES

[Na+].CC1=CC=C([O-])C=C1

InChI

InChIKey=ZECBPBHBGNLLMU-UHFFFAOYSA-M
InChI=1S/C7H8O.Na/c1-6-2-4-7(8)5-3-6;/h2-5,8H,1H3;/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C7H7O
Molecular Weight 107.1299
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

p-cresol, also known as also 4-methylphenol, is a unique bacterial metabolite from protein fermentation that is not produced by human enzymes, this metabolites has been frequently used to assess the degree of proteolytic fermentation. Recently investigation showed that p-cresol measurements might help to predict cardiovascular disease risk in renal patients over a wide range of residual renal function, beyond traditional markers of glomerular filtration. In addition, there were studies, which revealed, that urinary p-cresol was elevated in young French children with autism spectrum disorder.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Diagnostic
Unknown

Approved Use

Unknown
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG



Drug as perpetrator​Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
major [Km 58.4 uM]
major
major
major
minor [Km 50.3 uM]
minor
minor
minor
minor
no
no
no
no
no
no
no
no
no
no
unlikely
yes
yes
Sourcing

Sourcing

Vendor/AggregatorIDURL
PubMed

PubMed

TitleDatePubMed
Lithium-pilocarpine-induced status epilepticus in immature rats result in long-term deficits in spatial learning and hippocampal cell loss.
2001-10-19
Cortical devascularization: quantitative diffusion weighted magnetic resonance imaging and histological findings.
2001-10-12
Structural investigation of the biosynthesis of alternative lower ligands for cobamides by nicotinate mononucleotide: 5,6-dimethylbenzimidazole phosphoribosyltransferase from Salmonella enterica.
2001-10-05
Anterior cingulate cortex pathology in schizophrenia and bipolar disorder.
2001-10
Degradation products of cyanidin glycosides from tart cherries and their bioactivities.
2001-10
Cellular model for induction of drip loss in meat.
2001-10
Butylhydroxytoluene (BHT) increases susceptibility of transgenic rasH2 mice to lung carcinogenesis.
2001-10
Phosphorylation of cyclic adenosine monophosphate response element binding protein in oligodendrocytes in the corpus callosum after focal cerebral ischemia in the rat.
2001-10
Protective effects of glial cell line-derived neurotrophic factor on hippocampal neurons after traumatic brain injury in rats.
2001-10
Artificially induced unusual shape of erythrocytes: an atomic force microscopy study.
2001-10
Lipid peroxidation associated protein damage in rat brain crude synaptosomal fraction mediated by iron and ascorbate.
2001-10
Cytoprotective effect of Scutellaria baicalensis in CA1 hippocampal neurons of rats after global cerebral ischemia.
2001-10
Morphological and functional analysis of an incomplete CNS fiber tract lesion: graded crush of the rat optic nerve.
2001-09-30
Effect of antioxidants on preservation of motility,viability and acrosomal integrity of equine spermatozoa during storage at 5 degrees C.
2001-09-01
Electroantennogram and behavioural responses of the malaria vector Anopheles gambiae to human-specific sweat components.
2001-09
Antioxidant properties of evening primrose seed extracts.
2001-09
Sequence-structure analysis of FAD-containing proteins.
2001-09
Use of selective inhibitors and chromogenic substrates to differentiate bacteria based on toluene oxygenase activity.
2001-09
Oxidation of albumin is enhanced in the presence of uremic toxins.
2001-08-14
Antioxidant properties, autooxidation, and mutagenic activity of echinochrome a compared with its etherified derivative.
2001-08
Effect of the antioxidant ionol (BHT) on growth and development of etiolated wheat seedlings: control of apoptosis, cell division, organelle ultrastructure, and plastid differentiation.
2001-08
Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice.
2001-08
Long-term cortical atrophy after excitotoxic striatal lesion: effects of intrastriatal fetal-striatum grafts and implications for Huntington disease.
2001-08
New strategies for embedding, orientation and sectioning of small brain specimens enable direct correlation to MR-images, brain atlases, or use of unbiased stereology.
2001-07-30
Cyclin D1 as a proliferative marker regulating retinoblastoma phosphorylation in mouse lung epithelial cells.
2001-07-26
The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal.
2001-07-19
Influence of natural, electrically neutral lipids on the potentiometric responses of cation-selective polymeric membrane electrodes.
2001-07-15
Carbetapentane attenuates kainate-induced seizures via sigma-1 receptor modulation.
2001-07-13
Fluorescent probes for non-invasive bioenergetic studies of whole cyanobacterial cells.
2001-07-02
Generation of 8-epi-prostaglandin F(2alpha) in isolated rat kidney glomeruli by a radical-independent mechanism.
2001-07
Ca(2+) transport into an intracellular acidic compartment of Candida parapsilosis.
2001-06-29
Effects of the butylated hydroxyanisole and butylated hydroxytoluene on the DNA adduct formation and arylamines N-acetyltransferase activity in human colon tumor cells.
2001-06-09
Neuroprotective effect of melatonin on brain damage induced by acute global cerebral ischemia in cats.
2001-06-08
Iron-induced oxidative damage of corn root plasma membrane H(+)-ATPase.
2001-06-06
A highly efficient synthetic strategy for polymeric support synthesis of Le(x), Le(y), and H-type 2 oligosaccharides.
2001-06-01
Olfactory memory in the mosquito Culex quinquefasciatus.
2001-06
Field studies on efficacy of host odour baits for the biting midge Culicoides impunctatus in Scotland.
2001-06
Hydrogen peroxide inhibits photosynthetic electron transport in cells of cyanobacteria.
2001-06
A forebrain ischemic preconditioning model established in C57Black/Crj6 mice.
2001-05-30
Aluminium toxicity in the rat brain: histochemical and immunocytochemical evidence.
2001-05-15
Fused heterocyclic antioxidants: antioxidative activities of hydrocoumarins in a homogeneous solution.
2001-05
Distribution of serotonin immunoreactivity in the main olfactory bulb of the Mongolian gerbil.
2001-04
A solid phase reagent for the capture phosphorylation of carbohydrates and nucleosides.
2001-01-25
Advanced analytical determination of volatile organic compounds (VOC) and other major contaminants in water samples using GC-ion trap MS.
2001-01
Age-dependent consequences of seizures and the development of temporal lobe epilepsy in the rat.
2001
Automated, microprocessor controlled short path thermal desorption system for analysis of volatiles in foods.
2001
The antioxidant activity of BHT and new phenolic compounds PYA and PPA measured by chemiluminescence.
2001
Morphology of the leather defect light flecks and spots.
2001
1H NMR of compounds with low water solubility in the presence of erythrocytes: effects of emulsion phase separation.
2001
Percutaneous treatment of chronic MRSA osteomyelitis with a novel plant-derived antiseptic.
2001
Patents

Sample Use Guides

in rats: It was investigated the kinetic behavior of intravenously injected p-cresol (10 mg/kg) in rats with normal and decreased renal function, and compared the results with those obtained for creatinine (60 mg/kg) under similar conditions. Over a 4-hour period, p-cresol serum concentration showed only a minimal decline in rats with decreased renal function (t1/2 = 11.7 +/- 0.4 hours), compared to rats with normal renal function (t1/2 = 1.4 +/- 0.7 hours). The volume of distribution of p-cresol was approximately 4 times larger than that of creatinine, but was not significantly affected by renal failure. Not only renal, but also non-renal and total clearance, were much lower in rats with decreased renal function.
Route of Administration: Intravenous
It was investigated the in vitro impact p-cresol (PC) and p-cresyl sulfate (PCS) on monocyte chemoattractant protein-1 (MCP-1) expression via NF-kappa B (NF-κB) p65 in human vascular smooth muscle cells (VSMC). There was no significant difference in cell viability after toxins treatment for all concentrations tested. There was a significant increase in MCP-1 expression in cells treated with PCu and PCm (p < 0.001) and PCSn, PCSu and PCSm (p < 0.001), compared with the control. When VSMC were treated with the NF-κB p65 inhibitor plus PCu and PCm, there was a significant decrease in MCP-1 production (p < 0.005). This effect was not observed with PCS.
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:18:39 GMT 2025
Edited
by admin
on Mon Mar 31 22:18:39 GMT 2025
Record UNII
2K40O5HUMG
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
SODIUM P-METHYLPHENOLATE
Preferred Name English
SODIUM P-CRESOLATE
Common Name English
Code System Code Type Description
EPA CompTox
DTXSID6061523
Created by admin on Mon Mar 31 22:18:39 GMT 2025 , Edited by admin on Mon Mar 31 22:18:39 GMT 2025
PRIMARY
ECHA (EC/EINECS)
214-335-7
Created by admin on Mon Mar 31 22:18:39 GMT 2025 , Edited by admin on Mon Mar 31 22:18:39 GMT 2025
PRIMARY
PUBCHEM
23673456
Created by admin on Mon Mar 31 22:18:39 GMT 2025 , Edited by admin on Mon Mar 31 22:18:39 GMT 2025
PRIMARY
CAS
1121-70-6
Created by admin on Mon Mar 31 22:18:39 GMT 2025 , Edited by admin on Mon Mar 31 22:18:39 GMT 2025
PRIMARY
HSDB
5445
Created by admin on Mon Mar 31 22:18:39 GMT 2025 , Edited by admin on Mon Mar 31 22:18:39 GMT 2025
PRIMARY
FDA UNII
2K40O5HUMG
Created by admin on Mon Mar 31 22:18:39 GMT 2025 , Edited by admin on Mon Mar 31 22:18:39 GMT 2025
PRIMARY